VID24 Antibody

What is VID24 and what is its homolog in mammals?

VID24 (Vacuolar Import and Degradation 24) is a 41 kD protein first identified in yeast (Saccharomyces cerevisiae) that plays a critical role in the degradation pathway of fructose-1,6-bisphosphatase (FBPase). It is synthesized in response to glucose and localizes to FBPase-containing vesicles as a peripheral membrane protein . In mammals and other higher organisms, VID24's homolog is known as GID4 (GID Complex Subunit 4, VID24 Homolog), which functions as part of the GID complex involved in the ubiquitin-proteasome system for protein degradation .

What is the evolutionary conservation of VID24/GID4 across species?

VID24/GID4 demonstrates remarkable evolutionary conservation across eukaryotic species. According to BLAST analysis, the protein shows 100% identity across numerous species including humans, primates (chimpanzees, gorillas, gibbons), rodents (mice, rats), other mammals (elephants, pandas, dogs, bovines, bats, rabbits, horses), birds (turkeys, chickens), amphibians (Xenopus laevis), and fish (salmon, zebrafish) . This high degree of conservation suggests that VID24/GID4 performs a fundamental cellular function that has been maintained throughout evolution. Even more distant species like pufferfish show 92% identity, while beetles maintain 84% identity .

What is the primary function of VID24 in yeast?

In Saccharomyces cerevisiae, VID24 regulates the targeting of specific proteins for degradation, particularly FBPase. When yeast cells are transferred from medium containing poor carbon sources to fresh glucose, FBPase is targeted from the cytosol to specialized vesicles and then to the vacuole for degradation. VID24 plays a critical role in this process, specifically in facilitating the movement of FBPase from the vesicles to the vacuole . In the absence of functional VID24, FBPase accumulates in the vesicles and fails to move to the vacuole, suggesting that VID24 regulates the final step of this degradation pathway .

What epitopes should be targeted when selecting VID24/GID4 antibodies?

When selecting antibodies against VID24/GID4, the C-terminal region represents an optimal epitope target for several reasons. The C-terminus of GID4 shows remarkable conservation across species (up to 100% identity from humans to zebrafish), making antibodies against this region useful for cross-species studies . Commercial antibodies targeting the C-terminus of human GID4 have demonstrated high specificity and cross-reactivity with multiple species . For research focusing on specific species or requiring higher specificity, epitopes with greater sequence divergence between species might be preferred. The functional domains of VID24/GID4 should also be considered when selecting antibody epitopes, as antibodies targeting critical functional regions might be valuable for mechanistic studies but could potentially interfere with protein function in certain applications.

What validation procedures are essential for VID24/GID4 antibodies?

Rigorous validation of VID24/GID4 antibodies is crucial for reliable research outcomes. Essential validation procedures include:

• Genetic validation: Testing antibody reactivity in wild-type versus vid24/gid4 knockout or knockdown models to confirm specificity. This approach was used in the original VID24 studies to demonstrate antibody specificity .

• Western blot validation: Verifying that the antibody detects a protein of the expected molecular weight (approximately 41 kD for VID24 in yeast) .

• Cross-reactivity testing: Confirming the antibody's performance across relevant species, particularly important given the high conservation of GID4 across species .

• Immunoprecipitation validation: Assessing the antibody's ability to immunoprecipitate the target protein from complex lysates.

• Subcellular localization validation: Confirming that immunofluorescence patterns match the expected subcellular distribution (e.g., vesicular localization for VID24 in yeast) .

• Peptide competition: Demonstrating that pre-incubation with the immunizing peptide blocks antibody binding.

How does antibody structure influence VID24/GID4 detection specificity?

The structure of antibodies against VID24/GID4 significantly influences their specificity and performance in different applications. Several structural factors are particularly important:

• Complementarity-determining regions (CDRs): The CDRs, especially CDR3, define an antibody's epitope recognition specificity. Variation in CDR3 amino acid composition can dramatically alter binding specificity, allowing for design of antibodies that discriminate between similar epitopes .

• Binding modes: Different antibodies can adopt distinct binding modes when interacting with VID24/GID4, affecting their ability to recognize the target across species or in different conformational states. These binding modes determine whether an antibody can effectively discriminate between VID24/GID4 and closely related proteins .

• Clonality: Polyclonal antibodies against VID24/GID4, such as the commercial rabbit polyclonal antibody described in the search results , contain multiple antibody clones recognizing different epitopes. This provides broader recognition coverage but may increase the potential for cross-reactivity compared to monoclonal antibodies.

• Cross-specificity profiles: Antibodies can be designed with customized specificity profiles, either with high specificity for a particular version of VID24/GID4 or with cross-specificity that recognizes the protein across multiple species . This design consideration is particularly relevant given the high conservation of GID4 across species .

What are the optimal methods for studying VID24/GID4 localization?

Studying VID24/GID4 localization requires careful selection of methods based on the specific research question. The following approaches are particularly effective:

• Immunofluorescence microscopy: This technique was successfully employed in the original VID24 studies using monoclonal antibodies against HA-tagged VID24 . Cells were fixed and stained with primary antibodies (4 μg/ml, 30 min at room temperature) followed by FITC-conjugated secondary antibodies (5 μg/ml, 1 hour at room temperature) . Modern adaptations might employ confocal microscopy for improved resolution of subcellular structures.

• Subcellular fractionation: The VID24 studies effectively combined sucrose gradient fractionation with Western blotting to isolate and identify VID24-containing vesicles . This approach can be adapted for studying GID4 localization in mammalian cells through differential centrifugation followed by Western blotting of fraction proteins.

• Proteinase K protection assays: These assays can determine whether VID24/GID4 is exposed on the cytosolic face of membranes or protected within vesicles. The original studies treated vesicles with proteinase K with or without detergent to establish the topology of VID24 .

• Live-cell imaging: For dynamic studies, fluorescently tagged VID24/GID4 can be expressed and monitored in living cells, though care must be taken to ensure the tag doesn't interfere with localization or function.

How should Western blot protocols be optimized for VID24/GID4 detection?

Optimizing Western blot protocols for VID24/GID4 detection requires attention to several key factors:

• Sample preparation: For yeast VID24 studies, cells were grown in specific carbon source conditions to induce expression and then processed through TCA precipitation . For mammalian GID4, standard lysis buffers containing protease inhibitors are typically sufficient.

• Protein separation: The original VID24 studies successfully used 10% SDS-PAGE for protein separation , which provides good resolution in the 41 kD range where VID24 migrates.

• Transfer conditions: Transfer to nitrocellulose membranes as used in the VID24 studies is recommended. Standard transfer buffers containing methanol are typically suitable.

• Antibody selection: Commercial polyclonal antibodies targeting the C-terminus of GID4 have demonstrated good specificity across multiple species . For yeast VID24, antibodies against the native protein or epitope-tagged versions have been successfully employed .

• Controls: Include positive controls (samples known to express VID24/GID4), negative controls (samples from knockout/knockdown models if available), and loading controls (housekeeping proteins) to ensure consistent interpretation.

• Expected results: A single band at approximately 41 kD should be observed for VID24 in yeast . For GID4 in other species, the molecular weight may vary slightly but should be consistent with the predicted size based on amino acid sequence.

What methodological considerations exist for immunoprecipitation with VID24/GID4 antibodies?

Successful immunoprecipitation (IP) with VID24/GID4 antibodies requires careful consideration of several methodological factors:

• Antibody selection: Immunoaffinity purified polyclonal antibodies, such as the rabbit polyclonal antibodies described in the search results , are generally effective for IP studies.

• Cell lysis conditions: The lysis buffer should effectively solubilize VID24/GID4 while preserving relevant protein-protein interactions. For membrane-associated proteins like VID24 in yeast , include appropriate detergents like NP-40 or Triton X-100 at concentrations that solubilize the protein without disrupting important interactions.

• Antibody-to-protein ratio: Typically, 2-5 μg of antibody per 500-1000 μg of total protein provides good results, though this should be optimized empirically.

• Incubation conditions: Overnight incubation at 4°C with gentle rotation typically provides optimal antibody-antigen binding.

• Washing stringency: The washing stringency must balance removal of non-specific binding with preservation of specific interactions. For mechanistic studies of VID24/GID4 interactions, consider a gradient of salt concentrations in wash buffers.

• Controls: Always include input controls (pre-IP samples), negative controls (isotype-matched control antibodies), and beads-only controls to distinguish specific from non-specific interactions.

How can researchers investigate protein-protein interactions involving VID24/GID4?

Investigating protein-protein interactions involving VID24/GID4 requires a multi-faceted approach:

• Co-immunoprecipitation: Use VID24/GID4 antibodies to pull down the protein and its interacting partners from cell lysates. Analysis by mass spectrometry can identify novel interaction partners, while Western blotting can confirm suspected interactions. This approach is particularly valuable for identifying components of the vesicular machinery that interacts with VID24 in yeast or components of the GID complex in higher organisms.

• Proximity labeling: Fusing VID24/GID4 to a proximity labeling enzyme (BioID, APEX) allows biotinylation of nearby proteins in living cells. This approach can capture transient or weak interactions that might be lost in traditional co-IP experiments.

• Fluorescence-based interaction assays: Techniques like Fluorescence Resonance Energy Transfer (FRET) or Bimolecular Fluorescence Complementation (BiFC) can visualize VID24/GID4 interactions in living cells, providing spatial and temporal information about where and when interactions occur.

• Sucrose gradient fractionation: As used in the original VID24 studies , this approach can identify proteins that co-fractionate with VID24/GID4, suggesting they exist in the same complex or cellular compartment.

• Yeast two-hybrid screening: While this approach has limitations for membrane-associated proteins, modified versions might identify direct binding partners of specific domains of VID24/GID4.

What approaches can elucidate the role of VID24/GID4 in protein degradation pathways?

To elucidate the role of VID24/GID4 in protein degradation pathways, several complementary approaches can be employed:

• Time-course degradation studies: Monitor the degradation of target proteins (e.g., FBPase in yeast) at multiple time points after a stimulus (e.g., glucose addition) in wild-type versus vid24/gid4 mutant cells . This approach can reveal which stage of the degradation process requires VID24/GID4 function.

• Subcellular trafficking analysis: Use fluorescently tagged substrate proteins and VID24/GID4 to track their movements between cellular compartments during degradation. In yeast, this would involve monitoring FBPase movement from the cytosol to vesicles to the vacuole .

• Structure-function analysis: Generate truncations or point mutations in VID24/GID4 and assess their ability to restore proper degradation in vid24/gid4 mutant cells. This can identify functional domains and critical residues.

• Proteomic profiling: Compare the proteomes of wild-type and vid24/gid4 mutant cells to identify proteins whose abundance is regulated by VID24/GID4-dependent degradation. This approach can discover novel substrates beyond those already known.

• Reconstitution experiments: Attempt to reconstitute aspects of VID24/GID4-dependent degradation in cell-free systems to dissect the minimal requirements for function.

How does the role of VID24/GID4 differ between yeast and higher organisms?

The role of VID24/GID4 shows both conservation and divergence between yeast and higher organisms:

• Core function in protein degradation: In both yeast and higher organisms, VID24/GID4 plays a role in targeted protein degradation, suggesting evolutionary conservation of this fundamental function .

• Degradation mechanisms: In yeast, VID24 functions in the vacuolar import and degradation (VID) pathway, facilitating the movement of FBPase from specialized vesicles to the vacuole . In contrast, mammalian GID4 is primarily involved in the ubiquitin-proteasome system, reflecting an evolution in degradation mechanisms while maintaining the core function of targeted protein elimination.

• Metabolic regulation: In yeast, VID24 is synthesized in response to glucose and regulates the degradation of gluconeogenic enzymes when glucose becomes available . The metabolic regulatory function of GID4 in higher organisms is likely more complex and remains to be fully elucidated.

• Structural conservation: Despite potential functional divergence, the remarkably high sequence conservation of GID4 across species (100% identity across many organisms) suggests structural conservation that underlies its fundamental importance in cellular function.

• Physiological significance: In yeast, VID24 deletion abolishes FBPase degradation but doesn't cause dramatic phenotypes in growth, sporulation, or other processes . The physiological significance of GID4 in higher organisms may be broader, potentially affecting multiple cellular processes beyond metabolic regulation.

What experimental designs can reveal VID24/GID4 function in different metabolic conditions?

To investigate VID24/GID4 function across different metabolic conditions, the following experimental designs are particularly informative:

• Carbon source shift experiments: In yeast, shifting cells from poor carbon sources to glucose induces VID24 expression and FBPase degradation . Similar metabolic shift experiments in mammalian cells could reveal whether GID4 responds to specific metabolic cues.

• Nutrient deprivation studies: Subject cells to various forms of nutrient limitation (glucose, amino acids, lipids) and monitor changes in VID24/GID4 expression, localization, and activity through Western blotting and immunofluorescence.

• Metabolic disease models: Study VID24/GID4 expression and function in models of metabolic disorders like diabetes or obesity to determine whether altered VID24/GID4 function contributes to disease pathology.

• Comparative metabolomics: Compare metabolite profiles between wild-type and vid24/gid4 mutant cells under different metabolic conditions to identify metabolic pathways affected by VID24/GID4 function.

• Drug perturbation studies: Treat cells with compounds that alter specific metabolic pathways and assess the impact on VID24/GID4 expression, localization, and function to identify regulatory connections.

• Circadian rhythm analysis: Examine whether VID24/GID4 expression or function exhibits circadian patterns, particularly in tissues with strong metabolic circadian regulation like liver or adipose tissue.

• Exercise or fasting response: In animal models, determine whether VID24/GID4 expression or activity changes in response to physiological challenges like exercise or fasting that dramatically alter metabolic state.

How can researchers troubleshoot non-specific binding with VID24/GID4 antibodies?

Non-specific binding is a common challenge when working with antibodies. For VID24/GID4 antibodies, consider the following troubleshooting strategies:

• Antibody validation: Confirm antibody specificity using genetic controls (vid24/gid4 knockout or knockdown) to distinguish specific from non-specific signals.

• Blocking optimization: Test different blocking agents (BSA, non-fat dry milk, commercial blocking buffers) and concentrations to reduce background.

• Antibody titration: Determine the optimal antibody concentration that provides specific signal with minimal background. Start with the manufacturer's recommended dilution and test a range above and below.

• Washing stringency: Increase the number of washes or the stringency of wash buffers (higher salt concentration, addition of mild detergents) to reduce non-specific binding.

• Cross-adsorption: For polyclonal antibodies, consider pre-adsorbing with lysates from cells lacking VID24/GID4 to remove antibodies that recognize non-specific epitopes.

• Alternative detection methods: If non-specific binding persists in one application (e.g., Western blotting), try an alternative method (e.g., ELISA or immunoprecipitation) that might be less affected by the specific source of non-specificity.

• Epitope competition: Pre-incubate the antibody with the immunizing peptide to confirm which signals are specific (those that disappear with competition) versus non-specific (those that remain despite competition).

What are the key considerations when studying VID24/GID4 in different model organisms?

When studying VID24/GID4 across different model organisms, researchers should consider:

• Sequence conservation: While GID4 shows remarkable conservation across species (100% identity across many organisms) , subtle differences may exist that affect antibody recognition or protein function. Confirm antibody reactivity in each species of interest.

• Experimental conditions: The conditions that regulate VID24/GID4 expression and function may differ between organisms. In yeast, glucose stimulates VID24 expression , but the regulatory mechanisms in other organisms might involve different metabolic cues.

• Subcellular localization: VID24 in yeast localizes to specific vesicles as a peripheral membrane protein . The localization in other organisms may differ, reflecting adaptations to different cellular architectures and degradation mechanisms.

• Interaction partners: The proteins that interact with VID24/GID4 may vary between species, despite the high conservation of GID4 itself. Interaction studies should be performed in the specific organism of interest.

• Genetic tools: Consider the availability of genetic tools (knockout/knockdown models, genome editing capabilities) for studying VID24/GID4 in each organism. This may influence experimental design and interpretation.

• Physiological context: The physiological significance of VID24/GID4 may differ between organisms. In yeast, vid24 deletion affects FBPase degradation but has limited effects on growth or other processes . The phenotypic consequences in other organisms may be more diverse.